ABOUT ULYSSES
The ULYSSES Project is an innovative initiative dedicated to revolutionise cancer detection. Our mission is to develop a portable urine test that efficiently identifies cancer markers using advanced engineered yeast cells. Follow us on this exciting journey as we strive to make early cancer detection accessible and non-invasive for everyone.
ULYSSES is an Horizon Europe EIC Pathfinder Open project (grant agreement N. 101256857) with a budget of €2,991,106.25 (100% funded).
THE CONSORTIUM
The ULYSSES consortium brings together complementary expertise from industry, academia, and clinical research to accelerate the development of innovative cancer diagnostics. It includes D-Tails (Italy), University of Copenhagen (Denmark), University College London (United Kingdom) and Regina Elena National Cancer Institute (Italy).
D-Tails is an Italian deep-tech life science company developing innovative diagnostic technologies for the early, non-invasive detection of cancer and neurodegenerative diseases.
D-Tails
(Project Lead)
UCL is one of the world’s leading universities, known for its strong research profile, interdisciplinary approach, and commitment to tackling global challenges through innovation and collaboration.
University College London
The University of Copenhagen is Denmark’s largest university, with a strong international research profile and a long tradition of excellence in teaching and interdisciplinary collaboration.
University of Copenhagen
The Regina Elena National Cancer Institute is the largest comprehensive cancer center in central Italy and is a center of excellence for the study and treatment of a wide range of cancers.